ArticleCell death & disease2026

Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activity.

Dane M Newman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.